Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “VTV THERAPEUTICS LLC”

50 pharma patents match "VTV THERAPEUTICS LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 50
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 50 pharmaceutical patents matching "VTV THERAPEUTICS LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

50 results for “VTV THERAPEUTICS LLC” · 30,257 patents in full index Clear search

  1. US 10364233

    Piperidine derivative and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted
  2. US 10363241

    Substituted imidazole derivatives and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted
  3. US 10363244

    Compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted
  4. US 10287284

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted May 14, 2019 · Expires May 9, 2039

    granted
  5. US 10172840

    Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

    VTV THERAPEUTICS LLC · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  6. US 10085990

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  7. US 10064846

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  8. US 10030011

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted
  9. US 10004782

    Glucokinase activator compositions for the treatment of diabetes

    VTV THERAPEUTICS LLC · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  10. US 9968613

    Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

    VTV THERAPEUTICS LLC · Granted May 15, 2018 · Expires May 10, 2038

    granted
  11. US 9855274

    Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

    VTV THERAPEUTICS LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  12. US 9855251

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  13. US 9833457

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  14. US 9717710

    Treatment of mild and moderate Alzheimer's disease

    VTV THERAPEUTICS LLC · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted
  15. US 9707239

    Compounds that modulate oxidative stress

    VTV THERAPEUTICS LLC · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  16. US 9687489

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  17. US 9663481

    Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists

    VTV THERAPEUTICS LLC · Granted May 30, 2017 · Expires May 25, 2037

    granted
  18. US 9598375

    Substituted imidazole derivatives and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  19. US 9487493

    Use of a PPAR-delta agonist for treating muscle atrophy

    VTV THERAPEUTICS LLC · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  20. US 9447468

    Compounds that modulate oxidative stress

    VTV THERAPEUTICS LLC · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  21. US 9393245

    Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  22. US 9359313

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  23. US 9198901

    Tris(hydroxymethyl)aminomethane salts of a small-molecule GLP1R agonist and pharmaceutical compositions and uses thereof

    VTV THERAPEUTICS LLC · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  24. US 9175003

    Substituted azoanthracene derivatives and intermediates for preparation thereof

    VTV THERAPEUTICS LLC · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted